Focus on whole, minimally processed foods while limiting sugary snacks, fried foods, and sodas to minimize side effects and promote weight loss
Any changes in libido are likely indirect, resulting from weight loss, hormonal shifts, metabolic improvements, or psychological factors rather than direct drug effects on sexual physiology
The cost of tirzepatide, a GIP/GLP1 receptor agonist approved for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound), largely depends on three things: name brand or compounded medication paying with or without insurance your provider These factors can make your monthly cost swing anywhere from $25 to over $1,000
The incretin/glucagon system as a target for pharmacotherapy of obesity
To be clear, GLP-1s are not FDA-approved for treating these conditions right now, but if more research proves they are safe and effective, they could receive formal approval for these uses (or others) in the future